Skip to main content
Top
Published in: Supportive Care in Cancer 10/2019

01-10-2019 | Care | Original Article

Objective assessment of WHO/ECOG performance status

Authors: Miha Sok, Miha Zavrl, Boris Greif, Matevž Srpčič

Published in: Supportive Care in Cancer | Issue 10/2019

Login to get access

Abstract

Purpose

Performance status is an important factor in determining quality of life, the choice of treatment, and prognostic tool in patients. All scoring systems currently in use measure the patient’s performance subjectively. A new method of objective assessment of performance ECOG/WHO grades 2 and 3 was constructed and tested.

Methods

A performance meter—an adapted USB data logger with a mercury tilt switch—was constructed. The device was tested in a feasibility study on 33 residents of a retirement home. Parallel to the objective assessment, each resident gave their own estimate of their performance, and each resident was in turn assessed by the nursing staff.

Results

With the performance meter, 4 residents (12%) were assessed as PS ≥ 3 in comparison with 8 (24%) and 7 (21%) residents with an ECOG score ≥ 3 estimated by patients themselves and nursing staff respectively.

Conclusion

Subjective scoring—estimated by patients themselves and by nursing staff—showed underestimation of patients’ performance. In 12% of patients, a better performance score was observed with objective measurement in comparison with subjective assessment. Performance meter could be a useful tool for health care professionals for type of care decisions.
Literature
1.
go back to reference Yates JW, Chalmer B, McKegney FP (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45(8):2220–2224CrossRefPubMed Yates JW, Chalmer B, McKegney FP (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45(8):2220–2224CrossRefPubMed
2.
go back to reference Evans C, McCarthy M (1985) Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 1(8439):1204–1206CrossRefPubMed Evans C, McCarthy M (1985) Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 1(8439):1204–1206CrossRefPubMed
3.
go back to reference Hensing T, Cella D, Yount S (2005) The impact of ECOG performance status on quality of life symptoms in patients with advanced lung cancer. J Clin Oncol 23:8099CrossRef Hensing T, Cella D, Yount S (2005) The impact of ECOG performance status on quality of life symptoms in patients with advanced lung cancer. J Clin Oncol 23:8099CrossRef
4.
go back to reference Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Viganò A, Larkin P, De Conno F, Hanks G, Kaasa S (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by the Steering Committee of the European Association for palliative care.; steering Committee of the European Association for palliative care. J Clin Oncol 23(25):6240–6248 ReviewCrossRefPubMed Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Viganò A, Larkin P, De Conno F, Hanks G, Kaasa S (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by the Steering Committee of the European Association for palliative care.; steering Committee of the European Association for palliative care. J Clin Oncol 23(25):6240–6248 ReviewCrossRefPubMed
5.
go back to reference Chow R, Chiu N, Bruera E, Krishnan M, Chiu L, Lam H, DeAngelis C, Pulenzas N, Vuong S, Chow E (2016) Inter-rater reliability in performance status assessment among health care professionals: a systematic review. Ann Palliat Med 5(2):83–92CrossRefPubMed Chow R, Chiu N, Bruera E, Krishnan M, Chiu L, Lam H, DeAngelis C, Pulenzas N, Vuong S, Chow E (2016) Inter-rater reliability in performance status assessment among health care professionals: a systematic review. Ann Palliat Med 5(2):83–92CrossRefPubMed
6.
go back to reference Sargent DJ, Köhne CH, Sanoff HK, Bot BM, Seymour MT, de Gramont A, Porschen R, Saltz LB, Rougier P, Tournigand C, Douillard JY, Stephens RJ, Grothey A, Goldberg RM (2009) Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. J Clin Oncol 27(12):1948–1955CrossRefPubMedPubMedCentral Sargent DJ, Köhne CH, Sanoff HK, Bot BM, Seymour MT, de Gramont A, Porschen R, Saltz LB, Rougier P, Tournigand C, Douillard JY, Stephens RJ, Grothey A, Goldberg RM (2009) Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. J Clin Oncol 27(12):1948–1955CrossRefPubMedPubMedCentral
7.
go back to reference Su C, Zhou F, Shen J, Zhao J, O'Brien M (2017) Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced non-small cell lung cancer without epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations—still a daily challenge. Eur J Cancer 83:266–278CrossRefPubMed Su C, Zhou F, Shen J, Zhao J, O'Brien M (2017) Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced non-small cell lung cancer without epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations—still a daily challenge. Eur J Cancer 83:266–278CrossRefPubMed
8.
go back to reference Skipworth RJ, Stene GB, Dahele M, Hendry PO, Small AC, Blum D, Kaasa S, Trottenberg P, Radbruch L, Strasser F, Preston T, Fearon KC, Helbostad JL (2011) Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring. Clin Nutr 30(6):812–821CrossRefPubMed Skipworth RJ, Stene GB, Dahele M, Hendry PO, Small AC, Blum D, Kaasa S, Trottenberg P, Radbruch L, Strasser F, Preston T, Fearon KC, Helbostad JL (2011) Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring. Clin Nutr 30(6):812–821CrossRefPubMed
9.
go back to reference Kelly CM, Shahrokni A (2016) Moving beyond Karnofsky and ECOG performance status assessments with new technologies. J Oncol 2016:6186543 Published online 2016 Mar 15CrossRefPubMedPubMedCentral Kelly CM, Shahrokni A (2016) Moving beyond Karnofsky and ECOG performance status assessments with new technologies. J Oncol 2016:6186543 Published online 2016 Mar 15CrossRefPubMedPubMedCentral
10.
go back to reference Kelly CM, Shahrokni A (2016) From shelf to bedside-wearable electronic activity monitoring technologies might assist oncologists in functional performance status assessment of older cancer patients. Clin Colorectal Cancer 30:S1533–0028(16)30256–0 Kelly CM, Shahrokni A (2016) From shelf to bedside-wearable electronic activity monitoring technologies might assist oncologists in functional performance status assessment of older cancer patients. Clin Colorectal Cancer 30:S1533–0028(16)30256–0
11.
go back to reference Oken M, Creech R, Tormey D et al (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken M, Creech R, Tormey D et al (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5:649–655CrossRefPubMed
12.
go back to reference Dajczman E, Kasymjanova G, Kreisman H, Swinton N, Pepe C, Small D (2008) Should patient-rated performance status affect treatment decisions in advanced lung cancer? J Thorac Oncol 3(10):1133–1136CrossRefPubMed Dajczman E, Kasymjanova G, Kreisman H, Swinton N, Pepe C, Small D (2008) Should patient-rated performance status affect treatment decisions in advanced lung cancer? J Thorac Oncol 3(10):1133–1136CrossRefPubMed
13.
go back to reference Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC (2005) The Australia-modified Karnofsky performance status (AKPS) scale: a revised scale for contemporary palliative care clinical practice. BMC Palliat Care 4:7CrossRefPubMedPubMedCentral Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC (2005) The Australia-modified Karnofsky performance status (AKPS) scale: a revised scale for contemporary palliative care clinical practice. BMC Palliat Care 4:7CrossRefPubMedPubMedCentral
14.
go back to reference Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C (1999) Observer error in grading performance status in cancer patients. Support Care Cancer 7(5):332–335CrossRefPubMed Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C (1999) Observer error in grading performance status in cancer patients. Support Care Cancer 7(5):332–335CrossRefPubMed
15.
go back to reference Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D (2003) Performance status score: do patients and their oncologists agree? Br J Cancer 89(6):1022–1027CrossRefPubMedPubMedCentral Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D (2003) Performance status score: do patients and their oncologists agree? Br J Cancer 89(6):1022–1027CrossRefPubMedPubMedCentral
16.
go back to reference Maddocks M, Wilcock A (2012) Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure. Support Care Cancer 20(5):1113–1116CrossRefPubMed Maddocks M, Wilcock A (2012) Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure. Support Care Cancer 20(5):1113–1116CrossRefPubMed
17.
go back to reference Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, Tannock I (2008) Predictive model for survival in patients with advanced cancer. J Clin Oncol 26(36):5863–5869CrossRefPubMed Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, Tannock I (2008) Predictive model for survival in patients with advanced cancer. J Clin Oncol 26(36):5863–5869CrossRefPubMed
18.
go back to reference Suh SY, Choi YS, Shim JY, Kim YS, Yeom CH, Kim D, Park SA, Kim S, Seo JY, Kim SH, Kim D, Choi SE, Ahn HY (2010) Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer 18(2):151–157CrossRefPubMed Suh SY, Choi YS, Shim JY, Kim YS, Yeom CH, Kim D, Park SA, Kim S, Seo JY, Kim SH, Kim D, Choi SE, Ahn HY (2010) Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer 18(2):151–157CrossRefPubMed
19.
go back to reference Trédan O, Ray-Coquard I, Chvetzoff G, Rebattu P, Bajard A, Chabaud S, Pérol D, Saba C, Quiblier F, Blay JY, Bachelot T (2011) Validation of prognostic scores for survival in cancer patients beyond first-line therapy. BMC Cancer 11:95CrossRefPubMedPubMedCentral Trédan O, Ray-Coquard I, Chvetzoff G, Rebattu P, Bajard A, Chabaud S, Pérol D, Saba C, Quiblier F, Blay JY, Bachelot T (2011) Validation of prognostic scores for survival in cancer patients beyond first-line therapy. BMC Cancer 11:95CrossRefPubMedPubMedCentral
Metadata
Title
Objective assessment of WHO/ECOG performance status
Authors
Miha Sok
Miha Zavrl
Boris Greif
Matevž Srpčič
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Keyword
Care
Published in
Supportive Care in Cancer / Issue 10/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4597-z

Other articles of this Issue 10/2019

Supportive Care in Cancer 10/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine